KDNY
Morgan Stanley’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-408,746
| Closed | -$15.7M | – | 7797 |
|
|
2023
Q2 | $15.7M | Buy |
408,746
+156,906
| +62% | +$6.03M | ﹤0.01% | 2721 |
|
|
2023
Q1 | $5.83M | Sell |
251,840
-30,171
| -11% | -$698K | ﹤0.01% | 3656 |
|
|
2022
Q4 | $7.39M | Sell |
282,011
-3,447
| -1% | -$90.3K | ﹤0.01% | 3378 |
|
|
2022
Q3 | $5.61M | Buy |
285,458
+54,724
| +24% | +$1.08M | ﹤0.01% | 3583 |
|
|
2022
Q2 | $4.04M | Buy |
230,734
+95,835
| +71% | +$1.68M | ﹤0.01% | 3953 |
|
|
2022
Q1 | $2.21M | Buy |
134,899
+59,543
| +79% | +$975K | ﹤0.01% | 4447 |
|
|
2021
Q4 | $1.23M | Buy |
75,356
+5,455
| +8% | +$89K | ﹤0.01% | 4927 |
|
|
2021
Q3 | $891K | Buy |
69,901
+2,756
| +4% | +$35.1K | ﹤0.01% | 5126 |
|
|
2021
Q2 | $948K | Buy |
67,145
+65,907
| +5,324% | +$931K | ﹤0.01% | 5110 |
|
|
2021
Q1 | $19K | Sell |
1,238
-20,860
| -94% | -$320K | ﹤0.01% | 6740 |
|
|
2020
Q4 | $351K | Buy |
22,098
+9,088
| +70% | +$144K | ﹤0.01% | 5278 |
|
|
2020
Q3 | $32K | Sell |
13,010
-15,574
| -54% | -$38.3K | ﹤0.01% | 5886 |
|
|
2020
Q2 | $66K | Buy |
28,584
+16,423
| +135% | +$37.9K | ﹤0.01% | 5578 |
|
|
2020
Q1 | $33K | Sell |
12,161
-81,896
| -87% | -$222K | ﹤0.01% | 5628 |
|
|
2019
Q4 | $111K | Buy |
94,057
+63,211
| +205% | +$74.6K | ﹤0.01% | 5624 |
|
|
2019
Q3 | $32K | Sell |
30,846
-35,884
| -54% | -$37.2K | ﹤0.01% | 5880 |
|
|
2019
Q2 | $103K | Buy |
66,730
+38,782
| +139% | +$59.9K | ﹤0.01% | 5308 |
|
|
2019
Q1 | $111K | Sell |
27,948
-256,667
| -90% | -$1.02M | ﹤0.01% | 5347 |
|
|
2018
Q4 | $751K | Buy |
284,615
+69,127
| +32% | +$182K | ﹤0.01% | 4499 |
|
|
2018
Q3 | $1.58M | Buy |
215,488
+4,835
| +2% | +$35.5K | ﹤0.01% | 4181 |
|
|
2018
Q2 | $1.47M | Buy |
210,653
+109,926
| +109% | +$769K | ﹤0.01% | 4337 |
|
|
2018
Q1 | $936K | Sell |
100,727
-72,128
| -42% | -$670K | ﹤0.01% | 4585 |
|
|
2017
Q4 | $1.3M | Sell |
172,855
-39,002
| -18% | -$292K | ﹤0.01% | 4367 |
|
|
2017
Q3 | $2.26M | Buy |
211,857
+46,559
| +28% | +$496K | ﹤0.01% | 3756 |
|
|
2017
Q2 | $1.88M | Buy |
165,298
+54,228
| +49% | +$618K | ﹤0.01% | 3856 |
|
|
2017
Q1 | $1.2M | Sell |
111,070
-15,857
| -12% | -$171K | ﹤0.01% | 4245 |
|
|
2016
Q4 | $1.45M | Buy |
126,927
+96,112
| +312% | +$1.1M | ﹤0.01% | 4185 |
|
|
2016
Q3 | $383K | Buy |
30,815
+22,215
| +258% | +$276K | ﹤0.01% | 4683 |
|
|
2016
Q2 | $97K | Sell |
8,600
-8,546
| -50% | -$96.4K | ﹤0.01% | 5254 |
|
|
2016
Q1 | $220K | Buy |
17,146
+2,053
| +14% | +$26.3K | ﹤0.01% | 4918 |
|
|
2015
Q4 | $424K | Buy |
15,093
+8,649
| +134% | +$243K | ﹤0.01% | 4653 |
|
|
2015
Q3 | $124K | Sell |
6,444
-8,138
| -56% | -$157K | ﹤0.01% | 5319 |
|
|
2015
Q2 | $442K | Buy |
+14,582
| New | +$442K | ﹤0.01% | 4804 |
|